8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is very poor. This study aimed to evaluate hepatic arterial infusion chemotherapy (HAIC) versus sorafenib (SORF) in the treatment of HCC with PVTT.

          Related collections

          Author and article information

          Journal
          J Gastroenterol Hepatol
          Journal of gastroenterology and hepatology
          Wiley
          1440-1746
          0815-9319
          Aug 2020
          : 35
          : 8
          Affiliations
          [1 ] Gastrointestinal Tumor Center, Chongqing University Cancer Hospital, Chongqing, China.
          [2 ] Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
          [3 ] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
          [4 ] Hepatobiliary Pancreatic Tumor Center, Chongqing University Cancer Hospital, Chongqing, China.
          Article
          10.1111/jgh.15010
          32052876
          47483181-aeb3-41c5-a0d9-3f291dcc06db
          History

          hepatocellular carcinoma,sorafenib,portal vein tumor thrombosis,hepatic arterial infusion chemotherapy

          Comments

          Comment on this article